価格表

在庫・価格 : 2022年06月29日 00時47分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Cultrex PathClear Reduced Growth Factor BME, Type 2
データシート※最新のデータシートでない場合があります
3533-005-02 RSDアールアンドディー システムス
R&D Systems, Inc.(R&D Systemsは,テクネ コーポレイションの登録商標です)
5 ml ¥56,000 3個以上 追加

在庫・価格 : 2022年06月29日 00時47分 現在

Cultrex PathClear Reduced Growth Factor BME, Type 2

  • 商品コード:3533-005-02
  • メーカー:RSD
  • 包装:5ml
  • 価格: ¥56,000
  • 在庫:3個以上
使用文献
No. 文献情報 備考 参照
1 Klueh U et al. Crosslinked basement membrane-based coatings enhance glucose sensor function and continuous glucose monitoring in vivo. J Biomed Mater Res A 2018 Jan;106(1):7-16
Klueh U et al
2018/01/01
PubMed
2 Medina-Echeverz J et al. Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies. Nat Commun 2019 11;10(1):5041
Medina-Echeverz J et al
2019/01/01
PubMed
3 Driehuis E et al. Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy. J Clin Med 2019 Nov;8(11)
Driehuis E et al
2019/01/01
PubMed
4 Goldhammer N et al. Characterization of organoid cultured human breast cancer. Breast Cancer Res 2019 12;21(1):141
Goldhammer N et al
2019/01/01
PubMed
5 Fumagalli A et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell 2020 04;26(4):569-578.e7
Fumagalli A et al
2020/01/01
Species: Human PubMed
6 Gimeno-Valiente F et al. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Sci Rep 2020 02;10(1):3723
Gimeno-Valiente F et al
2020/01/01
Species: Human, Applications: Bioassay PubMed
7 Dekkers JF et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc 2021 04;16(4):1936-1965
Dekkers JF et al
2021/01/01
Species: Human, Applications: Bioassay PubMed
8 Hendriks D et al. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat Protoc 2021 01;16(1):182-217
Hendriks D et al
2021/01/01
Species: Human, Applications: Cell Culture PubMed
9 Krotenberg Garcia A et al. Active elimination of intestinal cells drives oncogenic growth in organoids. Cell Rep 2021 Jul;36(1):109307
Krotenberg Garcia A et al
2021/01/01
Species: Mouse, Applications: Bioassay PubMed
10 Driehuis E et al. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc 2020 10;15(10):3380-3409
Driehuis E et al
2020/01/01
Species: Human, Applications: Cell Culture PubMed
  • No.: 1
  • 文献情報:
    Klueh U et al. Crosslinked basement membrane-based coatings enhance glucose sensor function and continuous glucose monitoring in vivo. J Biomed Mater Res A 2018 Jan;106(1):7-16
    Klueh U et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Medina-Echeverz J et al. Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies. Nat Commun 2019 11;10(1):5041
    Medina-Echeverz J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Driehuis E et al. Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy. J Clin Med 2019 Nov;8(11)
    Driehuis E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Goldhammer N et al. Characterization of organoid cultured human breast cancer. Breast Cancer Res 2019 12;21(1):141
    Goldhammer N et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Fumagalli A et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell 2020 04;26(4):569-578.e7
    Fumagalli A et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gimeno-Valiente F et al. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Sci Rep 2020 02;10(1):3723
    Gimeno-Valiente F et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Dekkers JF et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc 2021 04;16(4):1936-1965
    Dekkers JF et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hendriks D et al. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat Protoc 2021 01;16(1):182-217
    Hendriks D et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Cell Culture
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Krotenberg Garcia A et al. Active elimination of intestinal cells drives oncogenic growth in organoids. Cell Rep 2021 Jul;36(1):109307
    Krotenberg Garcia A et al
    2021/01/01
  • 備考:
    Species: Mouse, Applications: Bioassay
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Driehuis E et al. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc 2020 10;15(10):3380-3409
    Driehuis E et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Cell Culture
  • 参照:
    PubMed